
Available to mentor

I am a physician scientist who studies inherited neurological disorders and a board-certified neurologist with specialty training in Movement Disorders and Neurogenetics. My lab studies nucleotide repeat expansion disorders, including work on Fragile X-associated disorders, C9orf72-associated ALS and Frontotemporal Dementia, Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome (CANVAS), Huntington's Disease and Myotonic Dystrophy. We use drosophila, mice and cell based (including human inducible pluripotent stem cells) model systems to explore the mechanisms underlying these diseases with a goal of developing novel therapeutics. We also explore novel means by which repetitive elements influence native neuronal function and contribute to common neurological conditions.
Clinically, I see patients with inherited neurodegenerative disorders, including Parkinson's Disease, Dementia, and Ataxia. I direct both the University of Michigan Fragile X Clinic and our Multidisciplinary Ataxia Clinic while also seeing patients and teaching residents and medical students at the Ann Arbor VA Medical Center. Administratively, I serve as Associate Chair for Research in the Department of Neurology at Michigan where I play active roles in faculty recruitment and retention, promotion, clinical trial infrastructure and help guide our department’s overall research strategy.
https://sites.google.com/site/toddlabmichigan/todd-lab
-
Center MemberPrecision Health Initiative
-
Todd P. 2025 Mar 13;PresentationConnective Voices in RNA Care: A Discussion on Patient Advocacy
-
Dykstra MM, Weskamp K, Gómez NB, Waksmacki J, Tank E, Glineburg MR, Snyder A, Pinarbasi E, Bekier M, Li X, Miller MR, Bai J, Shahzad S, Nedumaran N, Wieland C, Stewart C, Willey S, Grotewold N, McBride J, Moran JJ, Suryakumar AV, Lucas M, Tessier PM, Ward M, Todd PK, Barmada SJ. Cell Reports, 2025 Jan 28; 44 (1):Journal ArticleTDP43 autoregulation gives rise to dominant negative isoforms that are tightly controlled by transcriptional and post-translational mechanisms
DOI:10.1016/j.celrep.2024.115113 PMID: 39792557 -
Van Deynze K, Mumm C, Maltby CJ, Switzenberg JA, Todd PK, Boyle AP. Nucleic Acids Research, 2025 Jan 27; 53 (2):Journal ArticleEnhanced detection and genotyping of disease-associated tandem repeats using HMMSTR and targeted long-read sequencing
DOI:10.1093/nar/gkae1202 PMID: 39676678 -
Glineburg MR, Yildirim E, Gomez N, Rodriguez G, Pak J, Li X, Altheim C, Waksmacki J, Mcinerney GM, Barmada SJ, Todd PK. Nucleic Acids Research, 2024 Sep 9; 52 (16): 9745 - 9759.Journal ArticleStress granule formation helps to mitigate neurodegeneration
DOI:10.1093/nar/gkae655 -
Maltby CJ, Krans A, Grudzien SJ, Palacios Y, Muiños J, Suárez A, Asher M, Willey S, Van Deynze K, Mumm C, Boyle AP, Cortese A, Ndayisaba A, Khurana V, Barmada SJ, Dijkstra AA, Todd PK. Science Advances, 2024 Sep 6; 10 (36):Journal ArticleAAGGG repeat expansions trigger RFC1-independent synaptic dysregulation in human CANVAS neurons
DOI:10.1126/sciadv.adn2321 PMID: 39231235 -
Dykstra MM, Weskamp K, Gómez NB, Waksmacki J, Tank E, Glineburg MR, Snyder A, Pinarbasi E, Bekier M, Li X, Bai J, Shahzad S, Nedumaran J, Wieland C, Stewart C, Willey S, Grotewold N, McBride J, Moran JJ, Suryakumar AV, Lucas M, Tessier P, Ward M, Todd P, Barmada SJ. 2024 Jul 4;PreprintTDP43 autoregulation gives rise to shortened isoforms that are tightly controlled by both transcriptional and post-translational mechanisms.
DOI:10.1101/2024.07.02.601776 PMID: 39005384 -
Todd P. 2024 Sep 29;PresentationSession: Molecular Mechanisms that Drive Cell Function and Fate
-
Tseng YJ, Krans A, Malik I, Deng X, Yildirim E, Ovunc S, Tank EMH, Jansen-West K, Kaufhold R, Gomez NB, Sher R, Petrucelli L, Barmada SJ, Todd PK. Nucleic Acids Research, 2024 Jun 10; 52 (10): 5928 - 5949.Journal ArticleRibosomal quality control factors inhibit repeat-associated non-AUG translation from GC-rich repeats
DOI:10.1093/nar/gkae137 PMID: 38412259